fbpx

New Partner joins Lundbeckfonden Emerge

Andreas Jurgeit is to join Lundbeckfonden Emerge, the early stage investment unit of the Lundbeck Foundation, as a partner on 1 January 2019.

Andreas has been active in various operational and financing roles over the last decade. He was first exposed to biotech as a scientist collaborating with 3V Biosciences during his PhD and later joined Zurich-based venture investor Redalpine as Investment Manager. Most recently, as Director of the Merck Ventures Life Science team, he has conducted investments globally, with portfolio companies and board mandates in Europe, the US and Israel.

Andreas is 37 years old and is originally from Austria. He holds degrees in Molecular Biology from the University of Innsbruck and a PhD in Virology from the University of Zurich.

Related Posts

News

BONESUPPORT HOLDING AB (publ) announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
21. August 2019
Parkinson-symptomer invaderede fra tarmsystemet
Parkinson’s symptoms invade from the gut
18. July 2019
Muslinge-lim som erstatning for operationstråd
Mussel glue to replace surgical sutures
17. July 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge